Bone Health: Which Blood Tests Are Commonly Used?

Medical & affiliate disclosure: CTX Stat provides educational laboratory information and is not a substitute for professional medical advice, diagnosis, or treatment. CTX Stat may receive compensation from some outbound provider links when an affiliate program is active; provider comparisons and rankings are based on consumer fit, effective cost, access, policies, and reputation—not commission.

Quick take

Blood tests for bone health do not directly measure bone density, but they can help explain why bone loss, fractures, low bone mineral density, bone pain, or abnormal calcium levels may be happening. The most commonly used tests include 25-hydroxy vitamin D, calcium, phosphorus, magnesium, alkaline phosphatase, kidney function, liver function, parathyroid hormone, thyroid-stimulating hormone, and a complete blood count. Depending on your history, a clinician may also consider celiac screening, testosterone testing in men, serum protein electrophoresis, inflammatory markers, or bone turnover markers such as CTX and P1NP.

The key idea is that blood testing is usually supportive. Osteoporosis is generally evaluated with a bone mineral density test such as DXA, fracture history, age, medication exposure, and clinical risk factors. Blood tests are used to look for nutritional, hormonal, kidney, liver, digestive, blood, or medication-related contributors that may change treatment decisions.

What blood tests can and cannot show

Bone is living tissue. It is constantly remodeled through a balance of bone formation and bone resorption. Blood tests can reveal factors that influence that balance: vitamin D status, calcium regulation, parathyroid activity, kidney function, thyroid hormone levels, liver or digestive disease, inflammation, blood disorders, or signs of unusually high bone turnover.

However, a blood test usually cannot tell you how dense your bones are. For that, clinicians commonly use a bone mineral density test such as dual-energy x-ray absorptiometry, often called DXA or DEXA. The National Institute of Arthritis and Musculoskeletal and Skin Diseases explains that osteoporosis diagnosis and treatment decisions use bone density testing, fracture history, and risk factors—not blood tests alone. Blood and urine tests may be added when a provider suspects another medical condition is contributing to bone loss. See the NIAMS overview of osteoporosis diagnosis and treatment and MedlinePlus information on bone density scans.

This distinction matters because many people have osteoporosis or osteopenia with routine blood results in the reference range. Others have abnormal calcium, vitamin D, thyroid, kidney, or parathyroid results long before they have a formal bone density diagnosis. The most useful evaluation connects the lab findings with the clinical picture.

Common blood tests for bone health

The exact panel depends on the reason for testing. A person with an unexplained fragility fracture may need a broader workup than someone checking vitamin D after a previously low result. The Bone Health & Osteoporosis Foundation lists common laboratory tests used to evaluate possible causes of bone loss, including blood calcium, thyroid function, parathyroid hormone, testosterone in men, 25-hydroxy vitamin D, and biochemical markers such as NTX and CTX. Their patient guidance is available in the section on clinical exams and laboratory tests.

Test	What it helps evaluate	How it fits into bone health
25-hydroxy vitamin D	Vitamin D status	Vitamin D helps the body absorb calcium. Low levels may contribute to osteomalacia, secondary hyperparathyroidism, muscle weakness, falls, or poor response to osteoporosis therapy in some patients.
Calcium	Blood calcium level	Abnormal calcium may point toward parathyroid disease, kidney disease, vitamin D problems, malignancy, medication effects, or other disorders. Total calcium may be interpreted with albumin; ionized calcium may be used in selected cases.
Phosphorus and magnesium	Mineral balance	These minerals interact with vitamin D, kidney function, and parathyroid hormone. Abnormal results can affect bone mineralization and calcium regulation.
Comprehensive metabolic panel	Kidney function, liver enzymes, albumin, alkaline phosphatase, electrolytes	Kidney disease can alter vitamin D and PTH physiology. Liver disease, low albumin, or elevated alkaline phosphatase may change interpretation or suggest another process.
Alkaline phosphatase, including bone-specific ALP when needed	Bone or liver enzyme activity	Total ALP can rise from bone or liver sources. Bone-specific ALP may help clarify bone formation activity when total ALP is difficult to interpret.
Parathyroid hormone (PTH)	Parathyroid regulation of calcium and phosphorus	High PTH with high or high-normal calcium may raise concern for hyperparathyroidism. High PTH with low vitamin D or kidney disease can reflect secondary hyperparathyroidism.
TSH, sometimes free T4	Thyroid status	Excess thyroid hormone, including overtreatment with thyroid medication, can accelerate bone loss, especially in postmenopausal adults.
Complete blood count	Anemia, blood cell abnormalities, infection clues	CBC can help identify anemia, inflammation, or blood disorders that may coexist with bone pain, fractures, or systemic illness.
Celiac disease screening	Possible malabsorption	Untreated celiac disease can reduce absorption of calcium, vitamin D, and other nutrients, contributing to low bone density.
Testosterone and related hormones in men	Hypogonadism	Low testosterone is a recognized contributor to low bone density and fractures in men.
Serum protein electrophoresis	Abnormal blood proteins	Used selectively when clinicians are concerned about plasma-cell disorders such as multiple myeloma, especially with anemia, kidney problems, high calcium, bone pain, or unexplained fractures.

25-hydroxy vitamin D

The vitamin D test most often used for bone health is 25-hydroxy vitamin D, also written as 25(OH)D. MedlinePlus notes that most vitamin D blood tests measure 25(OH)D because it is the most accurate way to assess whether the body has enough vitamin D. The “active vitamin D” test, 1,25-dihydroxyvitamin D or calcitriol, is not usually used to check routine vitamin D stores; it may be used in kidney disease or certain calcium disorders. See MedlinePlus on the vitamin D test.

Vitamin D testing is common in bone evaluations, but routine screening of everyone is not universally recommended. The U.S. Preventive Services Task Force concluded that evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic, community-dwelling, nonpregnant adults. The Endocrine Society’s 2024 vitamin D guideline also discourages routine 25(OH)D screening in generally healthy adults who are not at increased risk. That does not mean vitamin D testing is useless; it means testing is most meaningful when there is a specific reason, such as low bone density, fracture, malabsorption risk, kidney disease, certain medications, or previous deficiency. See the USPSTF recommendation and the Endocrine Society guideline on vitamin D for prevention of disease.

Calcium, albumin, phosphorus, and magnesium

Only a small fraction of the body’s calcium is in the blood; most is stored in bones and teeth. A normal calcium blood test does not prove that bones are strong, because the body works hard to keep blood calcium in a narrow range. Still, abnormal calcium is important. MedlinePlus explains that too much or too little calcium in blood can be associated with bone disease, kidney disease, thyroid disease, parathyroid disorders, and other conditions. See MedlinePlus on the calcium blood test.

Total calcium is commonly reported as part of a comprehensive metabolic panel. Because a portion of calcium binds to albumin, low albumin can make total calcium look low even when biologically active ionized calcium is normal. Clinicians may correct calcium for albumin or order ionized calcium in certain situations. Phosphorus and magnesium add context because both are involved in bone mineralization and parathyroid-vitamin D physiology.

Parathyroid hormone

PTH is one of the most important hormones in calcium regulation. MedlinePlus describes PTH as a hormone that helps control calcium levels by affecting bone, kidneys, and intestinal calcium absorption. PTH is often ordered with calcium because the meaning of a PTH result depends heavily on the calcium result. See MedlinePlus on the PTH test.

For example, high calcium with a PTH that is not appropriately suppressed may suggest primary hyperparathyroidism. Low vitamin D can drive PTH upward as the body tries to maintain calcium balance. Chronic kidney disease can also elevate PTH. These patterns matter because treating an underlying parathyroid, kidney, or vitamin D problem may be part of improving bone health.

Kidney and liver function

Kidneys help activate vitamin D and regulate phosphorus, calcium, and PTH. Reduced kidney function can change mineral metabolism and complicate interpretation of bone turnover markers. Liver disease can affect vitamin D metabolism, nutrition, albumin, and clotting. A comprehensive metabolic panel is therefore a practical starting point in many bone evaluations because it includes creatinine, estimated kidney function, liver enzymes, albumin, electrolytes, and often calcium.

Alkaline phosphatase

Alkaline phosphatase, or ALP, is an enzyme found in several tissues, including liver and bone. MedlinePlus notes that ALP testing alone cannot identify the source of ALP in blood, so other tests are usually needed for diagnosis. See MedlinePlus on alkaline phosphatase testing. In bone health, ALP may be elevated with increased bone formation, healing fractures, osteomalacia, Paget disease of bone, or other high-turnover states, but liver and bile-duct conditions are also common reasons for elevated ALP. Bone-specific alkaline phosphatase may be ordered when the source is unclear.

Thyroid testing

Thyroid-stimulating hormone, or TSH, is commonly used to screen thyroid status. Excess thyroid hormone can contribute to bone loss, particularly if hyperthyroidism is untreated or thyroid medication dosing suppresses TSH more than intended. TSH may be followed by free T4 or other thyroid testing when results are abnormal or symptoms suggest thyroid disease.

CBC, celiac screening, and selected secondary-cause tests

Broader testing is often driven by clues: younger age, fractures from minimal trauma, unexplained weight loss, chronic diarrhea, anemia, kidney abnormalities, high calcium, bone pain, long-term glucocorticoid use, or unexpectedly rapid bone loss. The 2020 AACE/ACE osteoporosis guideline lists laboratory tests to consider when evaluating secondary osteoporosis, including serum chemistry with calcium, phosphate, liver enzymes, alkaline phosphatase and creatinine, CBC, 25-hydroxy vitamin D, and additional testing such as PTH, TSH, tissue transglutaminase antibodies for celiac disease, serum protein electrophoresis, and 24-hour urine calcium when indicated. The guideline is available as a PDF through the American Academy of Orthopaedic Surgeons quality-resource page for the AACE/ACE postmenopausal osteoporosis guideline.

Bone turnover markers: CTX, P1NP, NTX, and osteocalcin

Bone turnover markers are different from routine chemistry tests. They reflect the speed of bone remodeling rather than mineral levels. Common examples include:

• CTX, a marker of bone resorption, meaning breakdown of type I collagen from bone.
• P1NP, a marker of bone formation.
• NTX, another bone resorption marker that may be measured in urine or blood.
• Osteocalcin, a formation-related marker used less consistently in routine care.
• Bone-specific alkaline phosphatase, a formation marker that can be useful in selected settings.

The International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine have identified serum or plasma P1NP and beta-CTX as reference bone turnover markers for osteoporosis research and, in some settings, clinical monitoring. A recent consensus update emphasizes that these markers are most useful when patient preparation, sample handling, and assay consistency are controlled. See the open-access consensus paper on bone turnover markers in osteoporosis management and the IOF summary on standardisation of bone markers.

CTX and P1NP are not usually used to diagnose osteoporosis by themselves. Instead, clinicians may use them to establish a baseline before therapy, assess whether an antiresorptive medication is reducing resorption, evaluate adherence or absorption concerns, monitor anabolic therapy, or investigate unusual high-turnover patterns. Results can vary by age, sex, menopausal status, kidney function, recent fracture, time of day, fasting status, and the laboratory method used.

When clinicians consider bone-related blood testing

Bone health blood tests are most often considered when there is a reason to look beyond age-related bone loss. Examples include:

• A low-trauma fracture, especially of the hip, spine, wrist, humerus, pelvis, or rib.
• DXA results showing osteoporosis or unexpectedly low bone density for age.
• Rapid bone loss on repeat bone density testing.
• Osteoporosis in men, premenopausal women, or younger adults.
• Long-term use of medications associated with bone loss, such as glucocorticoids, aromatase inhibitors, androgen-deprivation therapy, certain antiseizure medicines, or excess thyroid hormone.
• Symptoms or history suggesting malabsorption, celiac disease, inflammatory bowel disease, kidney disease, thyroid disease, parathyroid disease, liver disease, eating disorder, heavy alcohol use, or endocrine disorders.
• High or low calcium, unexplained kidney stones, bone pain, anemia, or abnormal kidney function.

For men, the Endocrine Society’s osteoporosis guideline highlights the importance of laboratory testing to detect contributing causes in those at increased fracture risk. The guideline notes that secondary causes such as hyperparathyroidism, hyperthyroidism, kidney and liver disease, hypogonadism, hypercalciuria, and vitamin D deficiency may warrant evaluation depending on the clinical context. on osteoporosis in men.

How to prepare for bone health blood tests

Preparation depends on the specific test. Do not stop prescription medicines or supplements unless the ordering clinician tells you to. Bring a current medication and supplement list, including calcium, vitamin D, biotin, thyroid medication, osteoporosis drugs, steroids, antacids, and over-the-counter products.

Test type	Typical preparation questions to ask
Vitamin D, calcium, CMP, CBC, TSH, PTH	Ask whether fasting is needed, whether the test should be drawn at a certain time of day, and whether calcium, vitamin D, biotin, or thyroid medication timing matters for your situation.
CTX and some bone turnover markers	Ask about morning collection after an overnight fast. Food intake and circadian rhythm can affect CTX. Ask whether biotin should be held if you take high-dose biotin.
24-hour urine calcium	Ask for written collection instructions, whether to continue usual calcium intake, and what to do if a urine sample is missed during the collection period.
Celiac or hormone testing	Ask whether diet, time of day, menstrual cycle timing, or medication timing affects the result.

For CTX specifically, pre-analytical details matter. The IOF/IFCC consensus update notes that circadian changes and food intake affect beta-CTX and recommends collection for resorption markers between 7:30 and 10:00 a.m. after overnight fasting. Large commercial laboratory instructions also commonly recommend fasting morning samples for CTX and warn about possible biotin interference in some assays. See Labcorp’s specimen guidance for C-telopeptide as an example of the kind of preparation details that may apply.

How to interpret results without overreading them

Bone-related lab interpretation is pattern-based. A single number rarely gives the whole answer.

• Low vitamin D may matter more if calcium is low-normal, PTH is high, bone pain is present, malabsorption is suspected, or osteoporosis treatment is being planned.
• High calcium with non-suppressed PTH raises a different question than high calcium with very low PTH.
• Elevated alkaline phosphatase may come from liver or bone, so additional liver tests, gamma-glutamyl transferase, bone-specific ALP, imaging, or clinical history may be needed.
• High CTX may indicate higher bone resorption, but it can also be affected by recent fracture, kidney function, fasting status, time of day, age, and menopause.
• Normal labs do not exclude osteoporosis, especially in postmenopausal women and older men, where bone density and fracture risk may change even when routine labs are normal.

Reference ranges also vary. A result flagged “normal” or “abnormal” by the lab is not always the same as clinically optimal for a specific patient. PTH must be interpreted with calcium and vitamin D. Calcium may need albumin context. CTX and P1NP trends are most useful when the same method and similar collection conditions are used.

Cost and access considerations

The cost of blood tests for bone health varies widely. A basic metabolic panel, CBC, TSH, calcium, or vitamin D test is usually more available and less expensive than specialized markers such as CTX, P1NP, bone-specific alkaline phosphatase, or broad secondary-cause panels. Insurance coverage depends on the diagnosis code, plan rules, medical necessity, network status, and whether the test is preventive, diagnostic, or monitoring-related.

If you are paying out of pocket or comparing direct-pay options, compare the effective total cost. That means adding the advertised test price plus any mandatory clinician review fee, lab draw fee, processing fee, service fee, shipping fee for home-collection kits, and charges for repeat or confirmatory testing. Also check whether the test is available in your state, whether a physician order is included or required, where the specimen is collected, and whether results are reviewed by a licensed clinician.

For insured testing, ask the ordering office which diagnosis code will be used, whether the lab is in network, and whether prior authorization is needed. For self-ordered testing, consider whether the result will actually change your next step. A carefully chosen small panel ordered for a clear reason can be more useful than a large wellness panel with results that are hard to interpret.

What to discuss with a clinician after results come back

Useful follow-up questions include:

• Do these results suggest a correctable cause of bone loss?
• Do I need DXA, vertebral imaging, repeat DXA, or fracture-risk calculation?
• Are my calcium and vitamin D intake appropriate for my age, sex, kidney function, and medications?
• Could any of my medications be contributing to bone loss?
• Should abnormal calcium, PTH, thyroid, kidney, celiac, testosterone, or protein studies be repeated or referred to a specialist?
• If CTX or P1NP was ordered, what change would be considered meaningful, and when should it be repeated?

Blood testing is most valuable when it leads to a concrete decision: correcting a deficiency, evaluating parathyroid or thyroid disease, identifying malabsorption, adjusting medication, choosing an osteoporosis therapy, or monitoring whether treatment is having the expected biological effect.

 

FAQs

What blood tests are commonly used for bone health?

Common tests include 25-hydroxy vitamin D, calcium, phosphorus, magnesium, alkaline phosphatase, kidney and liver function tests, PTH, TSH, and CBC. Depending on the situation, clinicians may add celiac screening, testosterone testing in men, serum protein electrophoresis, inflammatory markers, 24-hour urine calcium, CTX, P1NP, NTX, or bone-specific alkaline phosphatase.

Can a blood test diagnose osteoporosis?

No. Osteoporosis is usually diagnosed with a DXA bone density test or by certain low-trauma fractures. Blood tests help identify contributors to bone loss and may guide treatment, but normal blood tests do not rule out osteoporosis.

Is vitamin D the main blood test for bone health?

Vitamin D is one of the most common, but it is not the only important test. Calcium, PTH, kidney function, thyroid status, and selected secondary-cause tests can be equally important depending on the person’s symptoms, fracture history, medications, and DXA results.

What is the difference between CTX and P1NP?

CTX is mainly a bone resorption marker, meaning it reflects bone collagen breakdown. P1NP is mainly a bone formation marker. Together, they can give a snapshot of bone remodeling, especially when monitoring osteoporosis treatment. They are not stand-alone diagnostic tests for osteoporosis.

Do I need to fast before a vitamin D or calcium test?

Often no, but instructions vary by lab and by what else is ordered at the same time. CTX is different: it is commonly collected in the morning after an overnight fast because food and time of day can affect results. Always follow the instructions from the ordering clinician or lab.

Why would a clinician order PTH with calcium?

PTH and calcium regulate each other. A PTH result is difficult to interpret without the calcium level. High PTH can be appropriate or inappropriate depending on whether calcium is low, normal, or high and whether vitamin D or kidney function is abnormal.

What if my bone health blood tests are normal but my DXA is abnormal?

That can happen. Many people with osteopenia or osteoporosis have normal routine labs. In that case, treatment decisions may rely more on bone density, fracture history, age, fall risk, medications, and fracture-risk tools, while labs help confirm that no obvious secondary cause has been missed.

Are home blood tests useful for bone health?

Home collection may be useful for some routine tests if the collection method is validated and the lab is reputable, but not every bone-related test is well suited to home collection. CTX and some specialty markers have timing and handling requirements that may make in-lab collection preferable.

Sources

• NIAMS: Osteoporosis diagnosis, treatment, and steps to take
• Bone Health & Osteoporosis Foundation: Clinical exams and laboratory tests
• MedlinePlus: Vitamin D test
• MedlinePlus: Calcium blood test
• MedlinePlus: Parathyroid hormone test
• MedlinePlus: Alkaline phosphatase test
• USPSTF: Vitamin D deficiency in adults—screening
• Endocrine Society: Vitamin D for the prevention of disease guideline
• Endocrine Society: Osteoporosis in men guideline
• ESCEO/IOF/IFCC consensus update: Bone turnover markers in osteoporosis